Rachel Culp-Hill

10PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2026
Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum.

|Nov 14, 2025
Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Tianyi Ling, Cristiana O'Brien, Jonathan R St-Germain

|Aug 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia.

Cristiana O'Brien, Nirvana Nursimulu, Anit Tyagi

|Aug 13, 2025
Utilizing Serum-Derived Lipidomics with Protein Biomarkers and Machine Learning for Early Detection of Ovarian Cancer in the Symptomatic Population.

Brendan M Giles, Rachel Culp-Hill, Robert A Law

|Apr 28, 2023
Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.

Rachel Culp-Hill, Brett M Stevens, Courtney L Jones

|Aug 22, 2022
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia.

Alessia Roma, Matthew Tcheng, Nawaz Ahmed

Pageof 2

Frequent Collaborators

8 joint publications

Angelo D'Alessandro

6 joint publications

Julie A Reisz

3 joint publications

Mark D Minden

2 joint publications

Kirk C Hansen